Division of Nephrology-Hypertension, University of California San Diego, La Jolla; Kidney Health, Research and Innovation Hub of San Diego, San Diego, CA.
Departments of Obstetrics and Gynecology, University of Washington, Seattle, WA.
Am J Kidney Dis. 2022 May;79(5):709-716. doi: 10.1053/j.ajkd.2021.08.015. Epub 2021 Sep 24.
RATIONALE & OBJECTIVE: Tubular secretion plays an important role in the efficient elimination of endogenous solutes and medications, and lower secretory clearance is associated with risk of kidney function decline. We evaluated whether histopathologic quantification of interstitial fibrosis and tubular atrophy (IFTA) is associated with lower tubular secretory clearance in persons undergoing kidney biopsy.
Cross-sectional.
SETTINGS & PARTICIPANTS: The Boston Kidney Biopsy Cohort is a study of persons undergoing native kidney biopsies for clinical indications.
Semiquantitative score of IFTA reported by 2 trained pathologists.
We measured plasma and urine concentrations of 9 endogenous secretory solutes using a targeted liquid chromatography/mass spectrometry assay. We used linear regression to test associations of urine-to-plasma ratios (UPRs) of these solutes with IFTA score after controlling for estimated glomerular filtration rate (eGFR) and albuminuria.
Among 418 participants, mean age was 53 years, 51% were women, 64% were White, and 18% were Black. Mean eGFR was 50mL/min/1.73m, and median urinary albumin-creatinine ratio was 819mg/g. Compared with individuals with≤25% IFTA, those with>50% IFTA had 12%-37% lower UPRs for all 9 secretory solutes. Adjusting for age, sex, race, eGFR, and urine albumin and creatinine levels attenuated the associations, yet a trend of lower secretion across groups remained statistically significant (P<0.05 for trend) for 7 of 9 solutes. A standardized composite secretory score incorporating UPR for all 9 secretory solutes using the min-max method showed similar results (P<0.05 for trend).
Single time point and spot measures of secretory solutes.
Greater IFTA severity is associated with lower clearance of endogenous secretory solutes even after adjusting for eGFR and albuminuria.
管状分泌在有效清除内源性溶质和药物方面起着重要作用,而较低的分泌清除率与肾功能下降的风险相关。我们评估了在接受肾活检的患者中,间质纤维化和肾小管萎缩(IFTA)的组织病理学定量是否与较低的管状分泌清除率相关。
横断面研究。
波士顿肾活检队列是一项针对因临床指征而接受原生肾活检的患者的研究。
由 2 名经过培训的病理学家报告的 IFTA 半定量评分。
我们使用靶向液相色谱/质谱分析测定 9 种内源性分泌溶质的血浆和尿液浓度。我们使用线性回归来检验这些溶质的尿液与血浆比值(UPR)与 IFTA 评分之间的关联,在控制估计肾小球滤过率(eGFR)和白蛋白尿后。
在 418 名参与者中,平均年龄为 53 岁,51%为女性,64%为白人,18%为黑人。平均 eGFR 为 50ml/min/1.73m,中位数尿白蛋白-肌酐比值为 819mg/g。与 IFTA 评分≤25%的患者相比,IFTA 评分>50%的患者所有 9 种分泌溶质的 UPR 均降低了 12%-37%。调整年龄、性别、种族、eGFR 以及尿液白蛋白和肌酐水平后,这些关联有所减弱,但 7 种溶质中仍存在组间分泌降低的趋势(趋势 P<0.05)。使用 min-max 方法,将所有 9 种分泌溶质的 UPR 纳入标准化复合分泌评分的方法也得到了类似的结果(趋势 P<0.05)。
内源性分泌溶质的单次时间点和点测量。
即使在调整 eGFR 和白蛋白尿后,IFTA 严重程度与内源性分泌溶质的清除率降低相关。